drugset / Trial / NCT02955056
Ankle Fractures Treated With Teriparatide
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a single site feasibility trial to test whether daily administration of Teriparatide, in participants with Weber type B ankle fractures that are being conservatively managed, is superior to the standard care treatment with regard to the rate of healing.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-10
- Completion
- 2017-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | — |
Indications
No indication recorded.